Clinical Trial Update: GP Vs PF As Induction Chemotherapy Combined with CCRT for Locoregionally Advanced Nasopharyngeal Carcinoma [Phase 3]

View source ↗

Summary

This document updates a Phase 3 trial comparing GP (gemcitabine plus cisplatin) versus PF (cisplatin plus fluorouracil) as induction chemotherapy with concurren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Nasopharyngeal Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• FLUOROURACIL (Fluorouracil)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms | Phase 3 | Status: ACTIVE_NOT_RECRUITING